Altimmune (ALT) EBITDA Margin (2010 - 2025)
Altimmune (ALT) reported EBITDA Margin of -111026.92% for Q4 2025, up 385633.08 percentage points from -496660.00% a year earlier and up 305613.08 percentage points from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) EBITDA Margin (2010 - 2025) Analysis & Trends
For FY2025, Altimmune posted EBITDA Margin of -230187.80%, up 284482.20 percentage points from FY2024.
- EBITDA Margin has a five-year change of -229523.54 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -514670.00% in FY2024 (-492268.83 pp), -22401.17% in FY2023 (+106929.71 pp), -129330.88% in FY2022 (-127145.78 pp) and -2185.10% in FY2021 (-1520.84 pp).
- The Q4 2025 figure ranks as the highest quarterly EBITDA Margin since Q4 2023.
- Year over year, EBITDA Margin has now increased in each of the last four quarters, with an average year-over-year change of -113812.79 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was Q3 2023 (a gain of 1238270.99 percentage points); the low point was Q3 2022 (a drop of 1223815.19 percentage points).
- Per Business Quant data, the three quarters before Q4 2025 came in at -416640.00% (Q3 2025), -457840.00% (Q2 2025) and -435720.00% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Altimmune | 575.64 Mn | 575.64 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -111,026.92% |
| Sep 30, 2025 | -416,640.00% |
| Jun 30, 2025 | -457,840.00% |
| Mar 31, 2025 | -435,720.00% |
| Dec 31, 2024 | -496,660.00% |
| Sep 30, 2024 | -494,600.00% |
| Jun 30, 2024 | -533,680.00% |
| Mar 31, 2024 | -533,740.00% |
| Dec 31, 2023 | -90,502.70% |
| Sep 30, 2023 | -6,379.01% |
| Jun 30, 2023 | -308,533.33% |
| Mar 31, 2023 | -105,309.52% |
| Dec 31, 2022 | -89,730.77% |
| Sep 30, 2022 | -1,244,650.00% |
| Jun 30, 2022 | -254,275.00% |
| Mar 31, 2022 | -60,562.50% |
| Dec 31, 2021 | -728.35% |
| Sep 30, 2021 | -20,834.81% |
| Jun 30, 2021 | -18,094.16% |
| Mar 31, 2021 | -1,764.56% |
API Access
Altimmune EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();